Novel Drug and Pharmaceutical Designs for Anti-Cancer Therapies
A special issue of Current Issues in Molecular Biology (ISSN 1467-3045). This special issue belongs to the section "Molecular Pharmacology".
Deadline for manuscript submissions: closed (31 March 2025) | Viewed by 242
Special Issue Editor
Interests: molecular biology of cancer; tumor pathology; molecular diagnosis; new drug research and development; health medical data analysis
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Cancer is one of the most prevalent and deadly diseases worldwide. Drug new (re)repurposing is a viable strategy for discovering new drugs in approved drugs by defining new indications.
We tried to summarize articles that inhibit cancer growth and are sensitive to anti-cancer drugs in vitro and in vivo, as well as explain the underlying chemoprevention patterns. We welcome articles on the development of new pharmacologically active compounds and the continued use of natural products such as synthetic and existing drugs as new drug developments. We welcome your original articles illuminating the challenges and opportunities in chemopreventive drug development. These can include new positioning of cancer therapeutics, selective optimization and reduction in side effects, sources and applications of synthetic drugs or drug metabolites as new drugs, drug delivery systems, and applications of nanomaterials. The manuscript collection will be published as a Special Issue of the journal.
Prof. Dr. Yi-Chiang Hsu
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Current Issues in Molecular Biology is an international peer-reviewed open access monthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2200 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- cancer therapeutics
- tumor antigens
- vaccine
- nanotechnology
Benefits of Publishing in a Special Issue
- Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
- Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
- Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
- External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
- e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.
Further information on MDPI's Special Issue policies can be found here.
